GenScript and Avectas link up to improve non-viral cell therapy processes by John Pinching | Sep 20, 2022 | News | 0 The two biotech leaders have embarked on a research project to streamline manufacturing Read More
Janssen buys into Legend’s CART therapy by Selina McKee | Dec 22, 2017 | News | 0 Janssen has entered into a global collaboration and license agreement with Legend Biotech USA and Legend Biotech Ireland to develop, manufacture and commercialise experimental CART-cell therapy LCAR-B38M. Read More